44 results on '"Dieckmann K"'
Search Results
2. Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases
3. Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
4. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
5. Treatment of testicular intraepithelial neoplasia (intratubular germ cell neoplasia unspecified) with local radiotherapy or with platinum-based chemotherapy: A survey of the German Testicular Cancer Study Group
6. Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
7. Myocardial infarction and other major vascular events during chemotherapy for testicular cancer
8. Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG)
9. 307P Incidence of neurological symptoms in brain metastases from breast cancer and its impact on prognosis: An analysis of 968 patients with brain metastases
10. 288MO Brain-only oligometastatic cancer patients present with longer overall survival than patients with extracranial involvement
11. 281MO Quality of life and neurocognitive function in patients with active brain metastases of HER2-positive breast cancer treated with trastuzumab-deruxtecan: Secondary endpoint analysis of the prospective single-arm phase II TUXEDO-1 trial
12. 165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial
13. Sensitive Detection of Antibodies in Patients with Acute Coxiella Burnetii Infection
14. 280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial
15. 369P Characterization of the inflammatory tumor microenvironment composition in brain metastases after failure of immune checkpoint inhibitor therapy
16. 343MO Clinical features and DNA methylation patterns in long- and short-term survivors of WHO grade II-III glioma
17. 345MO Treatment associated changes in the inflammatory microenvironment composition of brain metastases
18. 363O Clinical characterization of a real-life cohort of 6001 patients with brain metastases from solid cancers treated between 1986-2020
19. 418P - Markers of systemic inflammation correlate with survival prognosis in patients with newly diagnosed brain metastases
20. 403PD - Tumour mutational burden and immune infiltrates in primary renal cell carcinoma and matched brain metastases
21. 402PD - Impact of neurological symptom burden on the survival prognosis in a real-life cohort of patients with non-small cell lung cancer brain metastases
22. 395PD - Circulating PD-L1 levels vary across brain tumour entities and are oppositely linked to survival in glioblastoma and lower grade glioma patients
23. 379PD - Androgen receptor expression in breast cancer brain metastases
24. 378PD - Hypothyroidism is associated with improved survival prognosis in patients with newly diagnosed brain metastases
25. 372O - Mutational and inflammatory microenvironment characteristics in primary and matched local recurrent non-small cell lung cancer brain metastases
26. 1439O_PR - Paediatric radiation therapy across Europe: A European questionnaire survey supported by the SIOPe, ESTRO, PROS and several national paediatric hematology-oncology societies (NAPHOS)
27. The challenge to one-course carboplatin in seminoma clinical stage 1
28. 2928 Laboratory parameters have independent prognostic impact in patients with newly diagnosed brain metastases: analysis of 1201 cases
29. 2926 Tumor-infiltrating lymphocytes (TILs) and PDL1 expression in lung cancer brain metastases
30. 2923 Role of endocrine therapy in breast cancer (BC) patients with brain metastases
31. 2927 Programmed death ligand 1 (PD-L1) expression and tumor infiltrating lymphocytes in diffuse and anaplastic gliomas
32. 84P - Trimodality Therapy Including Radical Resection for Pancoast Tumors: T4 is not a Contraindication for Radical Surgery
33. 1O - Role of PDL1 Expression and Tumor Infiltrating Lymphocytes (TILS) in Glioblastoma (GBM) and Brain Metastases (BM)
34. 1455P - Outcome of Adolescents and Young Adults Versus Patients>30 Years with Ewing Sarcoma Family Tumors (Eft): Update on a Retrospective Single-Center Experience
35. 1324P - Tumor-Infiltrating Lymphocytes (Tils) and Pd-L1 Expression in Non- Small Cell Lung Cancer Brain Metastases (Bm) and Matched Primary Tumors (Pt)
36. 366P - Activity of T-Dm1 in Her2-Positive Breast Cancer Brain Metastases
37. 421P - Outcome and Molecular Characteristics of Young Adult Patients with Newly Diagnosed Primary Glioblastoma: A Study of the Society of Austrian Neurooncology (SANO)
38. 482 Analysis of risk factors associated with early development of brain metastases in breast cancer
39. Contralateral biopsies in patients with testicular germ-cell tumour—nuisance or new sense?
40. Stereotactic irradiation of uveal melanoma at a 6 MV-linear accelerator — Technical considerations concerning movement verification by video recording
41. Radiotherapy (XRT) for testicular intraepithelial neoplasia (TIN)
42. Contralateral Biopsies in Patients with Testicular Germ Cell Tumour — The German Experience
43. 922 - Chemotherapy of relapsing glioblastoma multiforme IV (GBM IV)with fotemustine (F) and dacarbacine (D)
44. 558 - Individually modified involved field technique of the German/Austrian Pediatric Hodgkin Study (HD90): A way to reduce treatment volume without increase of relaps
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.